Mr. Ross Haghighat
Haghighat is an Iranian American and the founder
and Chairman of the Board of Triton Systems, Inc.,
a leading edge nanotechnology company
in Boston, Massachusetts. Triton Systems incubates
solutions in the fields of life science and engineering,
advanced composite technologies.
Triton leverages US Government and private equity
funds to identify product gaps in the market place
and then develops product solutions that provide
step change for those markets where gaps exist.
Triton boasts a number of breakthrough products
which include; point of care diagnostic sensors
for myocardial injury, targeted nanotherapies
for breast cancer, flexible electronics, and advanced
aerospace composite structures.
Mr. Haghighat serves on the Board of Directors
of a number of high-tech firms in the Boston area,
including; Elecon, Inc., a development stage firm
focused on organic semiconductors, SI2, a early
stage firm focused on the development of passive
and active conformal electronic components, and
Triton BioSystems, a leading edge developer of
targeted therapy for late stage cancer patients.
Earlier in his career, he managed a high technology
group at a consulting firm for 7 years. Mr. Haghighat
holds graduate degrees in materials science, organometallic
chemistry, and in business administration.